Literature DB >> 27031087

Anticipated effects of alcohol stimulate craving and impair inhibitory control.

Paul Christiansen1, Emily Jennings1, Abigail K Rose1.   

Abstract

A considerable evidence base has demonstrated that priming doses of alcohol impair inhibitory control and activate motivation to consume alcohol. There is, however, a lack of studies investigating the effect of placebo-alcohol on these processes and their association with alcohol outcome expectancies (AOE). We investigated the effect of placebo-alcohol on craving and inhibitory control, and the extent to which placebo effects correlated with AOE in 32 nondependent drinkers. Participants completed questionnaires assessing typical alcohol use (fortnightly alcohol consumption, AUDIT) and AOE (measured using the Alcohol Outcome Expectancy Scale). On a within-subjects basis participants consumed a placebo-alcohol drink and control drink. Measures of craving were taken pre- and postdrink, and participants completed a go/no-go task following the drink. Craving was increased by the placebo-alcohol and, importantly, placebo-alcohol impaired inhibitory control. Furthermore expectancies of cognitive and behavioral impairment were correlated with go/no-go task performance following a placebo. Increases in craving were associated with a range of elevated outcome expectancies. This suggests that the anticipated effects of alcohol can impair inhibitory control and increase craving; therefore studies using placebo versus alcohol comparisons relative to studies using a pure no-alcohol control are underestimating the real-world effect of alcohol on these processes, which is a combination of pharmacological and anticipated effects of alcohol. Furthermore, individual differences in AOE may influence reactivity to the anticipated effects of alcohol. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Year:  2016        PMID: 27031087     DOI: 10.1037/adb0000148

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  7 in total

1.  Alcohol Expectancy and Cerebral Responses to Cue-Elicited Craving in Adult Nondependent Drinkers.

Authors:  Simon Zhornitsky; Sheng Zhang; Jaime S Ide; Herta H Chao; Wuyi Wang; Thang M Le; Robert F Leeman; Jinbo Bi; John H Krystal; Chiang-Shan R Li
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-12-12

2.  Cigarette-specific disgust aroused by smoking warning images strengthens smokers' inhibitory control under smoking-related background in Go/NoGo task.

Authors:  Xinwei Li; Weijian Li; Haide Chen; Ningmeng Cao; Boqiang Zhao
Journal:  Psychopharmacology (Berl)       Date:  2021-06-24       Impact factor: 4.530

3.  The Influence of Placebo Effect on Craving and Cognitive Performance in Alcohol, Caffeine, or Nicotine Consumers: A Systematic Review.

Authors:  María Nerea Galindo; José Francisco Navarro; María Cavas
Journal:  Front Psychiatry       Date:  2020-08-26       Impact factor: 4.157

4.  Severity of Topiramate-Related Working Memory Impairment Is Modulated by Plasma Concentration and Working Memory Capacity.

Authors:  Samuel P Callisto; Sílvia M Illamola; Angela K Birnbaum; Christopher M Barkley; Sai Praneeth R Bathena; Ilo E Leppik; Susan E Marino
Journal:  J Clin Pharmacol       Date:  2020-04-16       Impact factor: 3.126

5.  Bibi ergo sum: the effects of a placebo and contextual alcohol cues on motivation to drink alcohol.

Authors:  Paul Christiansen; Gareth Townsend; Graeme Knibb; Matt Field
Journal:  Psychopharmacology (Berl)       Date:  2017-01-07       Impact factor: 4.530

Review 6.  Drawing alcohol craving process: A systematic review of its association with thought suppression, inhibition and impulsivity.

Authors:  Laura Bernard; Laura Cyr; Agnès Bonnet-Suard; Christophe Cutarella; Vincent Bréjard
Journal:  Heliyon       Date:  2021-01-04

7.  The effect of beliefs about alcohol's acute effects on alcohol priming and alcohol-induced impairments of inhibitory control.

Authors:  Graeme Knibb; Carl A Roberts; Eric Robinson; Abi Rose; Paul Christiansen
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.